Suchergebnisse - (Person:"Widjaja, Ivy")

PubPharm (7)

1

A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

enthalten in: Nature communications | 2021

von Wang, C. | van Haperen, R. | Gutiérrez-Álvarez, J. | +15

2

Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections

enthalten in: Emerging infectious diseases | 2019

von Okba, N. | Raj, V. | Widjaja, I. | +12

3

Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection

enthalten in: Science advances | 2018

von Stalin Raj, V. | Okba, N. | Gutierrez-Alvarez, J. | +14

4

Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2018

von Li, W. | Hulswit, R. | Kenney, S. | +7

5

Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV

enthalten in: Journal of virology | 2016

von Widjaja, I. | Wicht, O. | Luytjes, W. | +5

6

Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics

enthalten in: PloS one | 2015

von Widjaja, I. | Rigter, A. | Jacobino, S. | +8

7

A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles

enthalten in: PloS one | 2013

von Rigter, A. | Widjaja, I. | Versantvoort, H. | +6

1
[1]